{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:18:06Z","timestamp":1778901486661,"version":"3.51.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In pulmonary medicine, aerosolization of substances for continuous inhalation is confined to different classes of nebulizers with their inherent limitations. Among the unmet medical needs is the lack of an aerosolized surfactant preparation for inhalation by preterm neonates, to avoid the risks associated with endotracheal intubation and surfactant bolus instillation. In the present report, we describe a high-concentration continuous powder aerosolization system developed for delivery of inhalable surfactant to preterm neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The developed device uses a technique that allows efficient aerosolization of dry surfactant powder, generating a surfactant aerosol of high concentration. In a subsequent humidification step, the heated aerosol particles are covered with a surface layer of water. The wet surfactant aerosol is then delivered to the patient interface (\n                      <jats:italic toggle=\"yes\">e.g<\/jats:italic>\n                      ., nasal prongs) through a tube.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The performance characteristics of the system are given as mass concentration, dose rate, and size distribution of the generated aerosol. Continuous aerosol flows of about 0.84\u2009L\/min can be generated from dry recombinant surfactant protein-C surfactant, with concentrations of up to 12\u2009g\/m\n                      <jats:sup>3<\/jats:sup>\n                      and median particle sizes of the humidified particles in the range of 3 to 3.5\u2009\u03bcm at the patient interface. The system has been successfully used in preclinical studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The device with its continuous high-concentration delivery is promising for noninvasive delivery of surfactant aerosol to neonates and has the potential for becoming a versatile disperser platform closing the gap between continuously operating nebulizers and discontinuously operating dry powder inhaler devices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jamp.2012.0996","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T14:28:12Z","timestamp":1361284092000},"page":"370-379","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":40,"title":["A Novel Continuous Powder Aerosolizer (CPA) for Inhalative Administration of Highly Concentrated Recombinant Surfactant Protein-C (rSP-C) Surfactant to Preterm Neonates"],"prefix":"10.1177","volume":"26","author":[{"given":"G.","family":"Pohlmann","sequence":"first","affiliation":[{"name":"Fraunhofer Institute for Toxicology and Experimental Medicine ITEM","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Iwatschenko","sequence":"additional","affiliation":[{"name":"MTF MediTech Franken GmbH","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Koch","sequence":"additional","affiliation":[{"name":"Fraunhofer Institute for Toxicology and Experimental Medicine ITEM","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Windt","sequence":"additional","affiliation":[{"name":"Fraunhofer Institute for Toxicology and Experimental Medicine ITEM","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rast","sequence":"additional","affiliation":[{"name":"Nycomed: a Takeda Company","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Gama","family":"de Abreu","sequence":"additional","affiliation":[{"name":"University Hospital Dresden","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.H.","family":"Taut","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceuticals International GmbH","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"De Muynck","sequence":"additional","affiliation":[{"name":"Nycomed: a Takeda Company","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-010-0201-4"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<222::AID-PPUL9>3.0.CO;2-O"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000337354"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.02.014"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072788"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32807fb013"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2009.0758"},{"key":"e_1_3_3_9_2","volume-title":"Aerosol Technology","author":"Hinds WC","year":"1999","unstructured":"Hinds WC. Aerosol Technology, 2nd. John Wiley & Sons: New York, 1999.","edition":"2"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9745-6_9"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-5-36"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04490653"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000297773"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1991.70.2.869"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2012.05.089"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.121285"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/02786820118725"},{"key":"e_1_3_3_18_2","unstructured":"Iwatschenko P Pohlmann G Windt H Koch W Kist M. Improved apparatus for the aerosolization of large volumes of dry powder. 2010WO 2010\/122103 A1."},{"key":"e_1_3_3_19_2","unstructured":"Pohlmann G Windt H Nolte O Koch W. Device for dosing dry nebulization. 2006WO 2006\/108558 A1."},{"key":"e_1_3_3_20_2","unstructured":"Rahmel D Taut F De-Muynck C Rast M Iwatschenko P Pohlmann G Koch W Windt H. Humidified particles comprising a therapeutically active substance. 2012WO 2012\/025496 A1."},{"key":"e_1_3_3_21_2","unstructured":"Iwatschenko P Pohlmann G Rahmel D Taut F De Muynck C Koch W Windt H. Device system for delivery of an aerosol to a patient on ventilatory support. 2012WO 2012\/020004 A1."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-5624-9.00018-4"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2007.04.005"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(92)90242-T"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2008.0686"},{"key":"e_1_3_3_26_2","first-page":"M1103","volume-title":"AAPS Annual Meeting and Exposition","author":"Pohlmann G","unstructured":"Pohlmann G, , Iwatschenko P, , Koch W, , Windt H, , Rast M, , Taut F, , De-Muynck C. Continuous powder aerosolization (CPA): a new device to administer inhalable particle formulations in high concentrations. AAPS Annual Meeting and Exposition, Chicago, IL, October 14\u201318, 2012, M1103."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60926-9"}],"container-title":["Journal of Aerosol Medicine and Pulmonary Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jamp.2012.0996","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jamp.2012.0996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jamp.2012.0996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:08:44Z","timestamp":1777644524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jamp.2012.0996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12,1]]}},"alternative-id":["10.1089\/jamp.2012.0996"],"URL":"https:\/\/doi.org\/10.1089\/jamp.2012.0996","relation":{},"ISSN":["1941-2711","1941-2703"],"issn-type":[{"value":"1941-2711","type":"print"},{"value":"1941-2703","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]}}}